Logo

addiction

Drugs to Treat Smoking Addiction Suggested by Multi-Ancestry Transcriptome-Wide Association Study

The new approach, called TESLA, enables eQTL datasets to be integrated with multi-ancestry GWAS, which the researchers applied to study smoking behaviors.

Proove Biosciences CEO Exonerated in PGx Test Kickback Case

Proove's founder and CEO was indicted last year on charges the company had defrauded Medicare and violated the Anti-Kickback Statute by paying physicians to use its pharmacogenetic tests.

Tobacco, Alcohol Use Contributors Uncovered With Multi-Ancestry GWAS

Researchers unearthed more than 3,800 tobacco or alcohol use-related variants using data for 3.4 million participants from four ancestry groups.

NIDA Awards Geisinger $973K to Study Genomics of Opioid Use Disorder

Researchers will use data from two biobanks, Geisinger's MyCode Community Health Initiative and Vanderbilt University’s BioVU.

IVitalize Acquires Genetic Testing Laboratory Geneus Health

Geneus offers a genetic test to identify potential genetic predisposition to reward deficiency syndrome, a primary marker for addiction.

Jan 15, 2019

Hundreds of Genetic Variants Implicated in Tobacco, Alcohol Use

Jun 6, 2018

FDA Grants Breakthrough Designation for AutoGenomics' Infiniti Neural Response Panel

Jan 18, 2018

AACC Drug Testing Guidelines Take Steps Toward Reducing Excessive Drug Panel Testing

Oct 9, 2017

U of Michigan Precision Health Effort Looking Beyond Genomics in Researching Opioid Crisis
Premium

Aug 29, 2017

Prescient Medicine Launches Addiction Risk Test Developed With AutoGenomics
Premium

Jan 11, 2017

NIH to Fund Research Into Genetics of Drug Addiction

Aug 10, 2016

Jackson Lab Receives $11.7 Million NIH Grant to Study Neurogenetics of Addiction

Jul 18, 2016

Proove Biosciences Building Opioid PGx Test Evidence; Experts Question Available Data
Premium

Mar 30, 2016

GWAS Identifies Loci Linked to Cannabis Dependence

Dec 6, 2013

NIDA to Fund Studies of Genes, Variants Involved in Addiction

Nov 25, 2013

NIDA to Fund Addiction-related Gene Studies in Animal Models

Jan 9, 2013

Dominion Diagnostics, LifeGen Conducting Validation Trial of Genomic Test for Addiction Risk
Premium

Dec 17, 2012

Dominion Diagnostics Licenses Rights to LifeGen Genetic Test Technology

Aug 31, 2012

GW, Maryland Use NIDA Funds to Find Addiction Genes

Jun 11, 2012

NIDA Wants Education Programs to Use Genetic Data in Addiction Research

Apr 2, 2012

NIDA to Prioritize Addiction Genetics Research Funding

Jan 19, 2011

Drug Abuse Institute Seeks PGx Proposals
Premium

Nov 19, 2010

NIH to Provide Grants for Addiction Genomics Research

Mar 25, 2009

Genetically Stratifying Smoking-Cessation Trials Could Save Up to $15M, Researchers Find
Premium

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.